Randomized phase III trial of concurrent chemoradiotherapy vs accelerated hyperfractionation radiotherapy in locally advanced head and neck cancer

The aim of this study was to compare the efficacy and safety of concurrent chemoradiotherapy (CCRT) vs accelerated hyperfractionation with concomitant boost (CCB) as a primary treatment for patients with Stage III–IV squamous cell carcinoma of head and neck (SCCHN). A total of 85 non-metastatic adva...

Descripción completa

Detalles Bibliográficos
Autores principales: Chitapanarux, Imjai, Tharavichitkul, Ekkasit, Kamnerdsupaphon, Pimkhuan, Pukanhapan, Nantaka, Vongtama, Roy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823777/
https://www.ncbi.nlm.nih.gov/pubmed/23740894
http://dx.doi.org/10.1093/jrr/rrt054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823777/
https://www.ncbi.nlm.nih.gov/pubmed/23740894
http://dx.doi.org/10.1093/jrr/rrt054

Ejemplares similares